DeVeau Michael sold $755K of IFF

DeVeau Michael (EVP, CFO) sold 8,825 shares of INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) at $85.55 ($0.75M total) on 2026-08-06.

Original reporting
SEC EDGAR · DeVeau Michael
Published Aug 7, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IFF
Neutral
high confidence
Mentioned
$IFF
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IFFNeutralLow
01

Why it matters

An EVP/CFO open-market sale of roughly $755k is disclosed, but the filing provides no new company performance or policy information.

02

Market read

Traders may note insider selling as a mild sentiment datapoint, but there is no fundamental catalyst in the text.

03

What to watch

No 10b5-1 plan is indicated, but the filing alone does not reveal intent, whether other tranches exist, or whether future sales are scheduled.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-07 after-hours; sale executed 2026-08-06

Background

The article is a primary-source SEC Form 4 insider transaction for International Flavors & Fragrances (IFF).

Company-level read

Ticker impact

$IFFNeutralHigh confidence
Context

IFF discloses CFO Michael DeVeau sold 8,825 shares on 2026-08-06 at $85.5490, totaling about $754,970.

Expected impact

Likely limited near-term impact; any effect would be small and short-lived unless followed by additional insider selling or new company-specific news.

Evidence & confidence

The filing is a disclosed transaction size and price, but it does not include new guidance, contracts, litigation, or operational changes that would reprice IFF fundamentals.

Market effects

Minimal; insider sales at a single large-cap fragrance/ingredients company typically do not change sector expectations.

None indicated.

None indicated.

Counterpoint

The sale may be driven by diversification, taxes, or pre-existing personal liquidity needs rather than a bearish view on IFF.

Key entities

  • INTERNATIONAL FLAVORS & FRAGRANCES INC

    Subject of the Form 4 insider transaction disclosure.

  • DeVeau Michael

    EVP, CFO who sold 8,825 shares on 2026-08-06.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IFFMedAI 8/10

International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

$IFFMed

International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.